Chiapparoli Logistica
Chiapparoli Logistica is an Italian pharmaceutical logistics operator founded in 1979 that provides GMP/GDP-compliant storage, distribution, cold chain, cryogenic storage, and AIFA-authorized secondary packaging across five Italian facilities, serving major pharmaceutical, veterinary, healthcare, nutraceutical, medical device, and cosmetics enterprises.
- Company typePrivate
- Founded1979
- HeadquartersMilano, Italy
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Chiapparoli Logistica does
Chiapparoli Logistica S.p.A. is an Italian pharmaceutical logistics and supply chain operator founded in 1979 and headquartered in Cerro al Lambro (Milan). The company provides GMP/GDP-compliant storage, distribution, and secondary packaging services for human and veterinary pharmaceuticals, narcotics, clinical trial materials, medical devices, nutraceuticals, and cosmetics. It operates five facilities totaling 100,000 m² with 150,000 pallet locations across northern and central Italy, including a 14,000 m² headquarters site, a multi-facility Livraga hub, and a 24,000 m² AIFA-authorized Officina Farmaceutica in Anagni that has been operational since 2017.
The company's core technology stack centers on RFID-enabled pharmaceutical traceability, Datamatrix and UDI serialization, end-to-end temperature monitoring (including cryogenic storage at -80°C and -196°C), and a proprietary GxP-validated logistics platform supporting process automation. It participates in Consorzio Dafne industry-wide RFID projects and has developed a 'Lean Logistics' operating model focused on eliminating non-value-added activity. The technology layer is complemented by extensive regulatory authorizations — AIFA, Italian Ministry of Health, AEO, TAPA, ISO 9001, ISO 14001, BIO/Euro Leaf (since 2018), ENAC, and Life Science Loading Council — which collectively constitute the operational backbone for pharmaceutical customers.
Chiapparoli generates revenue through enterprise logistics contracts, with a primary focus on pharmaceutical companies, and secondary exposure to veterinary, hospital/healthcare, nutraceutical, medical device, and cosmetics customers. The offering is structured around four service streams: core pharmaceutical logistics and distribution (treated as a recurring engagement), Officina Farmaceutica secondary packaging (professional services), customs clearance and bonded warehousing (transaction-based), and value-added logistics applied to production (professional services). The company is privately held by the founding Chiapparoli family, structured as an Italian S.p.A., and sells exclusively through direct enterprise account management with no public-facing developer API and a quote-based pricing model.
Chiapparoli Logistica firmographics
Firmographics- Name
- Chiapparoli Logistica
- Legal name
- Chiapparoli Logistica S.p.A.
- Website
- https://chiapparoli.it
- Company type
- Private
- Founded year
- 1979
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Chiapparoli Logistica is an Italian pharmaceutical logistics operator founded in 1979 that provides GMP/GDP-compliant storage, distribution, cold chain, cryogenic storage, and AIFA-authorized secondary packaging across five Italian facilities, serving major pharmaceutical, veterinary, healthcare, nutraceutical, medical device, and cosmetics enterprises.
- Ownership category
- akta.pro rank
Chiapparoli Logistica industry classification
Industry- Product category
- Pharmaceutical Logistics Services
- NAICS
- Refrigerated Warehousing and Storage (493120), Warehousing and Storage (493), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Packaging and Labeling Services (56191)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- GxP Warehousing, Storage & Distribution (ambient + controlled) (HLAGAMAH)
- akta.pro secondary industries
- Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD), Packaging, Labeling & Serialization Services (biologics/cold chain) (HLAAAKAJ), Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns) (HLAGAMAC), Pharmaceutical Cold-Chain Delivery (2–8°C / CRT) (TLAAAJAC), Medical Devices & Diagnostics (TLAIALAD)
Keywords
Where Chiapparoli Logistica is headquartered
LocationHeadquarters
- HQ city
- Milano
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
Chiapparoli Logistica business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Logistics & Distribution: Core logistics services including storage, handling, and distribution of pharmaceutical products with temperature-controlled environments.
- Secondary Packaging/Manufacturing: Officina Farmaceutica services including secondary packaging of pharmaceuticals for human and veterinary use, narcotics, nutritional products and clinical trials. Activities include package leaflets replacement, overprinting of variable data, replacement of packages, and application of optical labels.
- Customs Services: Customs clearance, bonded warehousing, VAT warehousing, and related services through in-house customs experts.
- Logistics Applied to Production: Value-added services including optical label traceability, quarantine management, reprocessing, display unit production, cold chain management, cryogenic storage, and direct-to-patient delivery.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Chiapparoli Logistica product offering
Product offeringCore offering
Chiapparoli Logistica provides end-to-end pharmaceutical logistics and supply chain services in Italy, including temperature-controlled warehousing, distribution, and value-added logistics. Its core service is the Officina Farmaceutica, an AIFA-authorized secondary packaging operation for human and veterinary drugs, narcotics, nutritional products, and clinical trial materials. Complementary offerings include customs clearance and bonded/IVA warehousing, RFID-enabled traceability, serialization (Datamatrix/UDI), cold chain and cryogenic storage (-80°C and -196°C), and a customer-facing Servizi Online portal.
Product overview
Chiapparoli Logistica offers a comprehensive logistics and supply chain service portfolio centered on pharmaceutical logistics. The core offering consists of Customer Service and Contact Center modules for client relationship management, supplemented by the Officina Farmaceutica (Pharmaceutical Workshop) for secondary packaging operations authorized by AIFA and the Italian Ministry of Health. Additional modules include Customs Services with AEO certification and Logistics Applied to Production covering serialization, cold chain, and cryogenic storage. Customers access services through the Servizi Online portal. The company operates a proprietary GxP-validated software platform for process automation and logistics management.
Differentiator
Problem solved
Functional benefit
Products and services
- Officina Farmaceutica (Pharmaceutical Workshop) Secondary packaging services for human and veterinary pharmaceuticals, narcotics, nutritional products, and clinical trial materials, including package leaflet replacement, overprinting of variable data, package replacement, and application of optical labels. Authorized by AIFA and the Italian Ministry of Health.
- Customs Services Customs clearance, T1/T2 transit, import and export declarations, bonded warehousing, and VAT (IVA) warehousing coordinated by in-house customs experts, leveraging AEO (Authorized Economic Operator) certification for simplified procedures.
- Logistics Applied to Production Value-added logistics services including optical label traceability, quarantine management, reprocessing, display unit production, serialization (Datamatrix and UDI codes), cold chain management, cryogenic storage at -80°C and -196°C, API storage, and temperature-controlled worldwide transport with last-mile temperature monitoring.
Quantifiable outcome
- Reduced costs through lean logistics processes
- +3 more outcomes
Companies that use Chiapparoli Logistica
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles3 records
Chiapparoli Logistica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Chiapparoli Logistica partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Consorzio DafnecoreActive participation in industry-wide projects promoted by Consorzio Dafne offering innovative supply chain services. Chiapparoli Logistica plays an active role in developing and implementing RFID technology projects for the pharmaceutical supply chain through this consortium.
- Enel XcoreSustainability partnership with Enel X for tracking green objectives and environmental reporting. The partnership has helped identify correct methods for achieving green sustainability goals, including GHG reporting and decarbonization planning.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Chiapparoli Logistica competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific (Patheon / Clinical Trial Services): Through Patheon and Fisher Clinical Services, Thermo Fisher offers pharma services including clinical trial logistics, cold chain, and packaging solutions. Overlaps with Chiapparoli's clinical trial materials handling and secondary packaging capabilities.
- DSV Healthcare Solutions: Global transport and logistics provider with healthcare/pharma specialty offering GDP-compliant warehousing and cold chain distribution. Acquired Panalpina and Schenker, expanding European pharma footprint that competes with Chiapparoli.
- DHL Supply Chain Life Sciences: Global contract logistics leader with dedicated Life Sciences division offering GDP-compliant warehousing, cold chain (2-8°C and cryogenic), and secondary packaging for pharma and medical devices across Europe including Italy. Directly competes with Chiapparoli for Italian pharma 3PL contracts with substantially larger scale and pan-European footprint.
- Kuehne+Nagel (KN PharmaChain): One of the world's largest pharma logistics specialists with KN PharmaChain network offering GxP-compliant warehousing, cold chain, and clinical trial logistics. Operates GDP-certified facilities across Europe and competes directly with Chiapparoli for Italian and pan-European pharma manufacturer contracts.
- UPS Healthcare (Marken / Polar Speed): UPS Healthcare division (including Marken for clinical trial logistics) offers GDP-compliant pharmaceutical warehousing, cold chain distribution, and direct-to-patient services globally. Comparable pharma logistics capability set to Chiapparoli with broader geographic reach.
- CEVA Logistics (CMA CGM Healthcare): Global 3PL with dedicated Healthcare & Pharma vertical offering GxP-compliant warehousing, cold chain, and secondary packaging services. Operates in Italy and competes directly with Chiapparoli for pharma distribution and storage contracts.
- Geodis Life Sciences & Healthcare: Global logistics provider with dedicated Life Sciences & Healthcare vertical offering GDP-compliant warehousing, cold chain, and pharma distribution. Operates in Italy and competes with Chiapparoli for healthcare and pharma contracts.
Direct peers
- Bomi Group: Italian-headquartered international pharma logistics specialist offering GxP-compliant warehousing, cold chain, and value-added services to pharma and medical device manufacturers. Closest direct peer to Chiapparoli by specialty, geography, and customer base.
- Movianto (Owens & Minor): European pharmaceutical distribution specialist offering warehousing, cold chain, and value-added services for pharma and medical device manufacturers. Owned by Owens & Minor, competes directly with Chiapparoli for European pharma 3PL contracts.
- Eurotranspharma: European pharma-specialized 3PL offering temperature-controlled distribution, warehousing, and last-mile delivery to pharmacies, hospitals, and pharma manufacturers across France, Benelux, Germany, and Italy. Direct peer with comparable pharma distribution focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Chiapparoli Logistica compliance and trust
Trust signalCompliance7 records
Chiapparoli Logistica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chiapparoli Logistica leadership team
Management profileNumber of profiles
Profiles4 records
Chiapparoli Logistica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chiapparoli Logistica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chiapparoli Logistica
What does Chiapparoli Logistica do?
Chiapparoli Logistica provides end-to-end pharmaceutical logistics and supply chain services in Italy, including temperature-controlled warehousing, distribution, and value-added logistics. Its core service is the Officina Farmaceutica, an AIFA-authorized secondary packaging operation for human and veterinary drugs, narcotics, nutritional products, and clinical trial materials. Complementary offerings include customs clearance and bonded/IVA warehousing, RFID-enabled traceability, serialization (Datamatrix/UDI), cold chain and cryogenic storage (-80°C and -196°C), and a customer-facing Servizi Online portal.
Is Chiapparoli Logistica a public or private company?
Chiapparoli Logistica is a private company. It is classified as family owned and is currently operating.
When was Chiapparoli Logistica founded?
Chiapparoli Logistica was founded in 1979. It employs 251 to 500 people.
Where is Chiapparoli Logistica based?
Chiapparoli Logistica is headquartered in Milano, Italy, in the Europe region.
How does Chiapparoli Logistica make money?
Four revenue lines are on record. Pharmaceutical Logistics & Distribution is the primary driver. The others are secondary Packaging/Manufacturing, customs Services and logistics Applied to Production.
Who are Chiapparoli Logistica's main competitors?
Broad incumbents on record are Thermo Fisher Scientific (Patheon / Clinical Trial Services), DSV Healthcare Solutions, DHL Supply Chain Life Sciences, Kuehne+Nagel (KN PharmaChain), UPS Healthcare (Marken / Polar Speed), CEVA Logistics (CMA CGM Healthcare) and Geodis Life Sciences & Healthcare. Direct peers are Bomi Group, Movianto (Owens & Minor) and Eurotranspharma.
Does Chiapparoli Logistica have an API?
No public API is recorded for Chiapparoli Logistica.
What industry is Chiapparoli Logistica in?
Chiapparoli Logistica's product category is Pharmaceutical Logistics Services. Its primary akta.pro industry code is HLAGAMAH, GxP Warehousing, Storage & Distribution (ambient + controlled), with a secondary code of TLAIACAD, Pharmaceutical & Life Sciences Warehousing (GDP-Compliant). Its NAICS code is 493120 and its SIC code is 5122.